It is also possible that ATAD3A oligomerization under AD conditions disrupts the ATAD3A/CYP46A1 complex, resulting in cholesterol disturbance and a negative feedback loop between cholesterol accumulation and CYP46A1 suppression. The gene discussed is ATAD3A; the disease is Alzheimer disease.